Correlation Between Connect Biopharma and Traws Pharma
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Traws Pharma, you can compare the effects of market volatilities on Connect Biopharma and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Traws Pharma.
Diversification Opportunities for Connect Biopharma and Traws Pharma
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Connect and Traws is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Traws Pharma go up and down completely randomly.
Pair Corralation between Connect Biopharma and Traws Pharma
Given the investment horizon of 90 days Connect Biopharma Holdings is expected to generate 1.32 times more return on investment than Traws Pharma. However, Connect Biopharma is 1.32 times more volatile than Traws Pharma. It trades about 0.04 of its potential returns per unit of risk. Traws Pharma is currently generating about -0.02 per unit of risk. If you would invest 87.00 in Connect Biopharma Holdings on September 5, 2024 and sell it today you would earn a total of 24.00 from holding Connect Biopharma Holdings or generate 27.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Connect Biopharma Holdings vs. Traws Pharma
Performance |
| Timeline |
| Connect Biopharma |
| Traws Pharma |
Connect Biopharma and Traws Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Connect Biopharma and Traws Pharma
The main advantage of trading using opposite Connect Biopharma and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.| Connect Biopharma vs. Candel Therapeutics | Connect Biopharma vs. Cingulate Warrants | Connect Biopharma vs. Unicycive Therapeutics | Connect Biopharma vs. Cardio Diagnostics Holdings |
| Traws Pharma vs. Crinetics Pharmaceuticals | Traws Pharma vs. Enanta Pharmaceuticals | Traws Pharma vs. Amicus Therapeutics | Traws Pharma vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |